Interestingly, GLP-1, GLP-1 analogues and GLP-1 mimetic have neuroprotective effective against AD neuropathology by activating brain GLP-1 receptors mainly in the microglia, neurons and astrocytes (Reich and Hölscher 2022). Here, GLP1R is linked to Alzheimer disease.